Organigram Holdings Inc. (TSE:OGI) Senior Officer Sells C$30,275.28 in Stock

Organigram Holdings Inc. (TSE:OGI) Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28.

Paolo De Luca also recently made the following trade(s):

• On Wednesday, September 11th, Paolo De Luca sold 13,835 shares of Organigram stock. The shares were sold at an average price of C$2.54, for a total value of C$35,140.90.
• On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The stock was sold at an average price of C$2.76, for a total value of C$28,334.16.

Organigram Price Performance

Shares of OGI opened at C$2.55 on Wednesday. The stock has a 50 day moving average of C$2.47 and a 200-day moving average of C$2.40. Organigram Holdings Inc. has a 52 week low of C$1.36 and a 52 week high of C$3.95. The firm has a market cap of C$276.85 million, a price-to-earnings ratio of -1.02, a PEG ratio of 0.42 and a beta of 1.13. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13.

Organigram (TSE:OGI) last released its earnings results on Tuesday, August 13th. The company reported C$0.03 earnings per share for the quarter, beating the consensus estimate of C($0.07) by C$0.10. Organigram had a negative net margin of 153.80% and a negative return on equity of 54.53%. The firm had revenue of C$41.06 million during the quarter, compared to analyst estimates of C$39.20 million. As a group, analysts forecast that Organigram Holdings Inc. will post 0.1632373 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group raised their price target on shares of Organigram from C$3.25 to C$3.60 and gave the stock a “speculative buy” rating in a research report on Wednesday, August 14th.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.